Since inception, ARMI has recognised the benefit of partnering with the world’s leading research organisations for mutual benefit. This has significantly helped the rapid development of the Institute’s research program and enhanced its international reputation.
Strategic linkages have been formed with organisations for their unique contribution to the Institute. These include:
CCRM Australia (Centre for Commercialization of Regenerative Medicine, Australia)
CCRM Australia is a not for profit established to address bottlenecks in the translation and commercialisation of regenerative medicine discoveries in Australia. Many of Australia’s leading researchers, industry, service providers and advocates have come together in the most extensive national regenerative medicine industry-led consortium to support the creation of CCRM Australia. ARMI has been instrumental in its formation. CCRM Australia is modelled on the highly successful CCRM in Canada. As a member of the Global CCRM network, CCRM Australia is a partner to a leading-edge industry consortium.
CCRM Australia brings to the Institute increased visibility to a global network of world-leading companies. It also provides business skills, leadership, potential funds for product development, and receptor capacity for technologies and products.
The Chinese University of Hong Kong (CUHK)
The CUHK-Monash University Innovation Alliance has been established as an integrated transnational collaboration to co-develop and co-invest in thematic areas of shared excellence in medical education and research. Synergistic collaborations are expected to lead to the development of high impact research programs and innovative medical education platforms.
Formed between the medical faculties of each university, the Alliance aims to generate collaborative research enterprises that will have long-term, significant impact on biomedical, health research and education for both institutions.
The research initiatives are currently focused on translational medicine:
- Stem cell biology and regenerative medicine
- Innovative medical devices
Specifically, the Institute for Tissue Engineering and Regenerative Medicine (iTERM) at CUHK has partnered with ARMI in the area of tissue engineering and regenerative medicine.
As an integral element of the alliance, ARMI is central to a PhD exchange program that has been established as a program of the Alliance. Selected PhD students enrolled in the ARMI program are co-supervised by key researchers from both ARMI and the CUHK Institute for Tissue Engineering and Regenerative Medicine.
The European Molecular Biology Laboratory and EMBL Australia
The Jackson Laboratory
Mount Desert Island Biological Laboratory
The Mount Desert Island Biological Laboratories (MDIBL) and ARMI have finalised an MOU that outlines the intent of the MDIBL and ARMI to collaborate in scientific, education and public and political relations activities that are mutually beneficial and serve to advance both organisations.
The new agreement is designed to facilitate the creation of an international exchange program between faculty and students at the two research institutions, including graduate students conducting PhD thesis research at the MDI Biological Laboratory and Monash University, and Monash University medical students.
The partnership also opens the possibility of developing biotech business connections between Maine and Australia in areas of shared interest.
In mid-2016, a memorandum of understanding on academic exchange between the Graduate School of Medicine, Osaka University and the Monash University Faculty of Medicine, Nursing and Health Sciences was signed. ARMI developed links with the researchers at Osaka University and nascent collaborative linkages were established as a result of the current joint appointment of ARMI and EMBL Australia Partner Laboratory Group Leader, A/Prof Mikaël Martino. ARMI is keen to use this dual appointment as a means to ensure ARMI and Monash University can realise the benefits proposed by the MOU. Of particular interest to ARMI, and by extension the FMNHS, is the Osaka University Graduate School’s Centre for Medical Innovation and Translation (CoMIT). The graduate school established CoMIT as a hub, to stand at the ‘crossroads between basic research and clinical practice’ and to seamlessly connect basic research, clinical research and medical practice. CoMIT works closely with companies to produce innovative technologies and translational research that draws on results of research by the Graduate School of Medicine, particularly in the areas of immunotherapy and regenerative medicine, as well as results of life science research by other faculties of Osaka University.
The Systems Biology Institute and SBI Australia
SBI Australia has been established at ARMI as the first node of Japan’s internationally recognised Systems Biology Institute.
The node connects and promotes collaboration between Japanese and Australian research and industry partners, and facilitates the sharing of scientific technology, resources and expertise. SBI Australia develops and supports the Australian systems biology research community, through the provision of training and advice, facilitation and making national and international linkages.
In the short time since its establishment, SBI Australia has attracted national and international attention. Unique research programs adopting a system biology approach have been progressing at ARMI with international collaborators.
ARMI is keen to expand its global collaborative network to South America. Intercontinental interactions over the last two years have resulted in the creation of an innovative South American Program.
The program aims to provide a mutually beneficial relationship with South American laboratories and researchers which includes:
- Establishment of research collaborations and exchange of scientific knowledge
- Provision of infrastructure and expertise
- Exchange of expertise and placement of competitive researchers at ARMI for doctoral or postdoctoral programs
Because of this program, ARMI has partnered with leading laboratories in Brazil and Chile to host a symposium series over a three-year period. Held in 2017 in Melbourne, Australia, the first ABC symposium was conducted over a two-day period with high profile researchers from all three countries.
The Australia Brazil Chile Regenerative Medicine and Developmental Biology Symposium Series (the ABC Symposia) is a long-term initiative developed by ARMI in conjunction with South American colleagues to strengthen relationships between ARMI and the active research currently undertaken in South America. Current participants include researchers from the Brazilian Biosciences National Laboratory, the University of Campinas in Brazil, the University of Chile and the Pontifical Catholic University of Chile.
The engagement with South American research organisations and researchers provides opportunities for unique collaborations, and through staff exchanges, support for the Institute’s early career researcher and student program recruitment.